A new study reveals that dropping even a small amount of weight improves general
well-being as well as improves bladder control in women with pre-diabetes.
A new study reveals that dropping even a small amount of weight improves general
well-being as well as improves bladder control in women with pre-diabetes.
People who suffer from pre-diabetes do not have diabetes yet, but they have higher-than-normal blood glucose levels.
The Diabetes Prevention Program, a clinical trial funded by the U.S. National Institutes of Health, involved to the study about 3,200 pre-diabetic, overweight women, averaging 50 years of age.
There were three groups to which the women were randomly attached: dietary changes and increased exercise aimed at achieving a 7 percent weight loss (660 women); treatment with the metformin, an oral diabetes drug (636 women); or treatment with a placebo (661 women).
Common medical pieces of advice about diet and weight loss were given to the last two groups.
The women who lost 5 to 7 percent of their starting weight thanks to changes in diet and exercise had fewer incidents of weekly incontinence compared to women in the other two groups-38 percent vs. 48 percent in the metformin group and 46 percent in the placebo group.
Dr. Jeanette S. Brown of the University of California, San Francisco, the head study’s author said in a prepared statement: “Our findings reinforce the Diabetes Prevention Program’s good news about the benefits of modest weight loss. A 200-pound woman who loses 10 to 15 pounds not only lowers the risk of developing type 2 diabetes but also improves bladder control.”
Brown added: “If you’re a woman at risk for type 2 diabetes, preventing or delaying diabetes and improving bladder control are powerful reasons to make these lifestyle changes.”
The main result of The Diabetes Prevention was reported in 2002. It proved that changes in diet and boost exercise which led to a weight loss of 5 percent to 7 percent also diminished the onset of type 2 diabetes by 58 percent. Thanks to the treatment with metformin the risk was diminished by 31 percent.
